Testing effectiveness (Phase 2)Study completedNCT00705003
What this trial is testing
Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)
Who this might be right for
Major Depressive Disorder
Massachusetts General Hospital 142